Study Overview

This randomized phase III trial studies how well erlotinib hydrochloride compared to placebo works in treating patients with stage IB-IIIA non-small cell lung cancer that has been completely removed by surgery.

By clicking "Contact Research Team", your contact information will be
sent securely to the research staff associated with the study. You will also receive a copy of this
email in your inbox, as well as other notifications to determine your participation status in the
study.